United States · FDA National Drug Code directory
Tizanidine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-492_cf7c5bb7-d94b-4c98-a4a2-e6a917e4165b
- Product NDC
- 46708-492
- Form
- CAPSULE
- Composition / generic term
- Tizanidine Hydrochloride
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200115
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 80 BLISTER PACK in 1 CARTON (46708-492-08) / 8 CAPSULE in 1 BLISTER PACK · 46708-492-08
- 30 CAPSULE in 1 BOTTLE (46708-492-30) · 46708-492-30
- 150 CAPSULE in 1 BOTTLE (46708-492-41) · 46708-492-41
- 1000 CAPSULE in 1 BOTTLE (46708-492-91) · 46708-492-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →